Keytruda is a medication that is used to treat various types of cancer. It is an expensive drug, and patients may face difficulty in affording it. However, there are some discounts and financial support programs available for Keytruda.

Merck, the manufacturer of Keytruda, offers financial assistance to eligible patients through the Merck Access Program. This program provides free medication to eligible patients who do not have insurance coverage or have inadequate coverage. Additionally, the program offers co-pay assistance to eligible patients with commercial insurance. The program has income eligibility criteria, and patients can check their eligibility and apply for assistance through the program's website [2].

Moreover, the website drugpatentwatch.com provides information on the patents and exclusivity of Keytruda. This information can help patients and healthcare providers understand the market competition and pricing of Keytruda [1].

Overall, patients who need Keytruda but cannot afford it should explore the financial assistance programs available through the Merck Access Program. Additionally, patients can use drugpatentwatch.com to understand the market competition and pricing of Keytruda.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] https://www.merckaccessprogram-keytruda.com/hcc/affordability.html
[3] https://www.keytruda.com/financial-support/